QA: Neubase Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001173281_2016_Neubase_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001173281', 'EntityCommonStockSharesOutstanding': 30331309, 'Assets': 46370807, 'AssetsCurrent': 29036036, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 17073775, 'Liabilities': 3880014, 'LiabilitiesAndStockholdersEquity': 46370807, 'LiabilitiesCurrent': 3880014, 'LiabilitiesNoncurrent': 0, 'NetIncome': -15197865, 'PropertyPlantAndEquipmentNet': 248753, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 12243, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 42490793, 'remainder_NetIncome': -15197865, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001173281', 'EntityCommonStockSharesOutstanding': 35961396, 'Assets': 29445013, 'AssetsCurrent': 13285008, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 15949131, 'Liabilities': 4481866, 'LiabilitiesAndStockholdersEquity': 29445013, 'LiabilitiesCurrent': 4481866, 'LiabilitiesNoncurrent': 0, 'NetIncome': -25766198, 'PropertyPlantAndEquipmentNet': 198631, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 12243, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 24963147, 'remainder_NetIncome': -25766198, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Edgar->Model Mapping